BioVie Inc

BIVINASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

7.54M

on 2026-06-30, from 610K on 2024-03-31 10-K ↗

Earlier counts are adjusted for the 1-for-10 and 1-for-10 reverse splits; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

$300.0M

S-3 of 2026-06-18. 1 prospectus supplement filed under it since. S-3 ↗

$6.5M

A.G.P./Alliance Global Partners, agreement of 2026-09-14. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

7.90M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-K ↗

Cash

1.9 quarters

$9.0M on 2026-06-30 ÷ $4.8M a quarter of operating cash used, the average of four quarters. 10-K ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-08-07	Public offering	6,000,000	$2.00	$12.0M	424B5 ↗

Also on file: a 1-for-10 reverse split, 2025-07-07 8-K ↗